Paul Sugarbaker is a Surgical Oncologist in Washington, Washington, D.c.. Dr. Sugarbaker is rated as an Elite provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Stomach Cancer, Endoscopy, and Pancreaticoduodenectomy.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Edward Tanner, M.D., is a professor of gynecologic oncology in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and the medical director for women’s health in the Johns Hopkins National Capital Region. Dr. Tanner is an internationally recognized expert in gynecologic surgery and is known for his surgical skills, compassionate bedside manner, leadership and teaching abilities. Dr. Tanner’s clinical interests include surgical management of advanced gynecologic cancers, including radical debulking surgery for ovarian cancer, as well as minimally invasive surgery for early-stage female cancers. He is particularly focused on developing innovative techniques that reduce complications and speed recovery time. His research interests include sentinel lymph node mapping in endometrial and cervical cancers, exploring ways to reduce complications for patients having surgery for advanced ovarian cancer, robotic single-site surgery and identifying new treatments for patients with uterine sarcoma. He has authored more than 80 articles in peer-reviewed medical journals and has lectured nationally and internationally on sentinel lymph node techniques, uterine sarcoma and surgical innovations for gynecologic cancer. He is the chapter author of “Surgery for Endometrial Cancer” in Telinde’s Operative Gynecology, the definitive textbook for gynecologic surgery techniques in the United States. Dr. Tanner is a member of the NRG Corpus Committee, which develops clinical trials for uterine cancer on behalf of the National Cancer Institute. A Maryland native, Dr. Tanner received his medical degree from the University of Alabama at Birmingham before returning to Baltimore to complete his residency in gynecology and obstetrics at The Johns Hopkins Hospital. He completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center, where he was among the first fellows to complete an extensive training program in robotic surgery for gynecologic cancers. Dr. Tanner has served as a faculty member at The Johns Hopkins Hospital as well as the Marcia Stenn Professor and chief of gynecologic oncology at Northwestern University in Chicago. Having served as the gynecologic oncology fellowship program director at both The Johns Hopkins Hospital and Northwestern Memorial Hospital, Dr. Tanner taught the next generation of gynecologic surgeons and health care leaders. Dr. Tanner is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Valerie Lee, M.D., is a medical oncologist with the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an instructor of medical oncology at Johns Hopkins University School of Medicine. Dr. Lee has an expertise in management of gastrointestinal malignancies, including gastric, colon and pancreatobiliary cancers. Dr. Lee earned her medical degree from the Columbia University College of Physicians and Surgeons. She completed a residency in internal medicine at New York Presbyterian Hospital, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine. Dr. Lee is currently earning her Certificate in Science of Clinical Investigation at Johns Hopkins Bloomberg School of Public Health. Dr. Lee is a member of the American Society of Clinical Oncology. Dr. Lee manages multiple early phase trials and her work has been published in peer-reviewed journals. Her research interests include clinical trials for patients with gastrointestinal malignancies, and combining traditional chemotherapies with immunotherapy to improve survival and quality of life for patients. She has received a Cancer Center Training grant for research on molecular targets for cancer detection and treatment and has spoken at numerous conferences on updates in gastrointestinal malignancies. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Pancreaticoduodenectomy.

Dr. Mildred R. Chernofsky is a gynecologic oncologist at Sibley Memorial Hospital and an associate professor in obstetrics and gynecology at George Washington University School of Medicine and the Uniformed Services University of the Health Sciences (USUHS). She practices out of the Sibley Center for Gynecologic Oncology and Advanced Pelvic Surgery. Dr. Chernofsky is affiliated with Sibley Memorial Hospital and George Washington University Hospital. With a focus on gynecology and obstetrics, Dr. Chernofsky has an expertise in advanced laparoscopy, gestational trophoblastic disease and robotic surgery. Dr. Chernofsky earned her medical degree from Pennsylvania State University College of Medicine. She completed a general internship and a residency in obstetrics and gynecology at the National Naval Medical Center of San Diego, as well as a fellowship in gynecologic oncology at the Los Angeles County/University of Southern California Medical Center. Dr. Chernofsky was named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly in 2012 and 2014. She was also named a Top Doctor in the D.C. region by Washingtonian Magazine. Dr. Chernofsky is also a fellow of the American Congress of Obstetricians and Gynecologists. Dr. Chernofsky has clinical interests in uterine, ovarian, cervical and vulvar cancers, as well as genital dysplasia. She has contributed to numerous clinical trials in her position as a principal investigator for Gynecologic Oncology Group (GOG), as well as various publications and presentations. Dr. Chernofsky also participates in patient educational forums both locally and those sponsored by the Foundation for Women’s Cancer. Dr. Chernofsky is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Endometrial Cancer, and Hysterectomy.

Dr. Mary Wilkinson is a medical oncologist caring for patients with breast cancer and gyn malignancies. Dr. Wilkinson sees patients primarily at Sibley Memorial Hospital in Washington DC. She also serves as clinical director of the Under Armour Breast Health Innovation Center at the Sidney Kimmel Comprehensive Cancer Center. Dr. Wilkinson received her undergraduate degree in electrical engineering from Rice University and earned her M.D. from Stanford University School of Medicine. She completed her residency and performed a fellowship in hematology and oncology at the University of California, San Francisco. Dr. Wilkinson joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Wilkinson was director of breast cancer research at the Inova Schar Cancer Institute and president of Medical Oncology Hematology Associates of Northern Virginia. She also spent time on the faculty at Georgetown University and the University of California, San Francisco. Dr. Wilkinson is a member of the American Society of Clinical Oncology. Dr. Wilkinson is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer.

Mark Steves is a Surgical Oncologist and a General Surgeon in Silver Spring, Maryland. Dr. Steves is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Pseudomyxoma Peritonei, Familial Colorectal Cancer, Pancreatic Cancer, Pancreatectomy, and Gastrectomy. Dr. Steves is currently accepting new patients.

John Marshall is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Marshall is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Hepatectomy, and Pancreatectomy.

"Dr. Ari D. Fishman is a hematologist affiliated with Sibley Memorial Hospital, Holy Cross Hospital and George Washington University Hospital, where he serves as an assistant professor of medicine for the School of Medicine. He practices out of Maryland Oncology and Hematology, located in Wheaton, Maryland and Silver Spring, Maryland. Dr. Fishman earned his medical degree from Sackler School of Medicine. He completed a residency in internal medicine at the Beth Israel Medical Center, followed by a fellowship in hematology and oncology at the Montefiore Medical Center. Dr. Fishman previously worked at Washington Oncology Hematology Center, located in Washington, D.C. and Chevy Chase, Maryland. Dr. Fishman has been named a Top Doctor in Hematology and Oncology by Washingtonian Magazine and a Top Doctor by Consumers’ Checkbook magazine. Dr. Fishman is a member of the American College of Physicians and the American Society of Clinical Oncology. Dr. Fishman has contributed to numerous publications. Selected Publications Fishman AD, Hoffman A, Volterra F, Frymus M, Gentilluci M. ""Intracaval and intracardiac metastatic nonseminomatous germ cell tumor: a rare cause of hemolytic anemia and thrombocytopenia."" Cancer Invest. 2002;20(7-8):996-1001.". Dr. Fishman is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndrome (MDS), and Childhood Iron Deficiency Anemia.

Carolyn Hendricks is a Hematologist Oncology specialist and an Oncologist in Bethesda, Maryland. Dr. Hendricks is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Triple-Negative Breast Cancer, and HER-2 Positive Breast Cancer. She is board certified in American Board Of Internal Medicine.

Nicholas Farrell is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Farrell is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Iron Deficiency Anemia.

Hamid Lari is a primary care provider, practicing in Hospital Medicine in Washington, Washington, D.c.. Dr. Lari is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Stroke, Sepsis, Lymphangitis, Bone Marrow Aspiration, and Endoscopy.

Michael Lee is a primary care provider, practicing in Hospital Medicine in Washington, Washington, D.c.. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pneumonia, Endoscopy, and Gastrostomy.

Dr. James Xu received a bachelor of science in chemical engineering with a minor in mathematics from Brigham Young University and his medical degree from University of Minnesota. He completed his internal medicine residency at the Yale-New Haven Hospital of Yale University in New Haven, CT, and his hematology and medical oncology fellowship at the New York-Presbyterian Hospital of Columbia University in New York City. Because of his unique background in engineering and medicine, Dr. Xu was the recipient of the American Society of Clinical Oncology-Conquer Cancer Foundation Young Investigator Award in 2011 and Merit Award in 2012. Dr. Xu is a strong advocate of precision medicine and he is the first person to have proposed and preliminarily confirmed the feasibility of using deep sequencing technology to detect genetic mutation in rare cell samples such as circulating tumor cells from cancer patients’ peripheral blood. He has published in peer-reviewed journals in lung, breast, and pancreatic cancers. Dr. Xu is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Pulmonary Embolism, Deep Vein Thrombosis, Protein S Deficiency, and Congenital Antithrombin 3 Deficiency.

"Shannon C. O'Connor, M.D., is a medical oncologist with Suburban Hospital. She practices out of Maryland Oncology Hematology. Dr. O'Connor has expertise in hematology and medical oncology with a special focus in women's health, including breast cancer and gynecologic cancers. Dr. O'Connor earned her Master's Degree in Physiology at Georgetown University, followed by her medical degree from St. George's University School of Medicine. She completed a residency at Washington Hospital Center, as well as a fellowship in hematology and oncology. Dr. O'Connor is a member of the American Society of Clinical Oncology, the American Society of Hematology, the Montgomery County Medical Society and the American Medical Association. Selected Publications Catlett JP1, Williams SA, O'Connor SC, Krishnan J, Malkovska V. ""Primary lymphoma of bone: an institutional experience."" Leuk Lymphoma. 2008 Nov;49(11):2125-32. doi: 10.1080/10428190802404030.". Dr. O'connor is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Paget Disease of the Breast, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Breast Cancer.

John O'boyle is an Oncologist and an Obstetrics and Gynecologist in Silver Spring, Maryland. Dr. O'boyle is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Testicular Yolk Sac Tumor, Hysterectomy, and Bladder Reconstruction. Dr. O'boyle is currently accepting new patients.

Sarah Temkin is a Gynecologic Oncologist and an Oncologist in Washington, Washington, D.c.. Dr. Temkin is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Hysterectomy, and Oophorectomy.

Cheryl Aylesworth is a Hematologist and an Oncologist in Bethesda, Maryland. Dr. Aylesworth is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Ovarian Cancer.